Progress in Treating Obesity-Related Hypertension
In early trials, the novel investigational medication lorundrostat significantly lowered aldosterone production and safely lowered blood pressure in individuals with uncontrolled hypertension. It was particularly effective in those with obesity.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
